{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:19:08Z","timestamp":1790864348414,"version":"4.1.0"},"reference-count":20,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,11,25]],"date-time":"2003-11-25T00:00:00Z","timestamp":1069718400000},"content-version":"vor","delay-in-days":2338,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:p><jats:bold>Summary. <\/jats:bold> Antibody to hepatitis E virus of IgG class (anti\u2010HEV IgG) is regularly detected in industrialized countries, where HEV is non\u2010endemic, at levels not exceeding 2\u20133%; seropositive individuals are often found in certain groups of patients and professionals exposed to an increased risk of blood\u2010borne infections. The present study was aimed at the identification of anti\u2010HEV IgG in patients with human immunodeficiency virus (HIV) infection, including acquired immune deficiency syndrome (AIDS), living in Russia and Belarus, an area of low anti\u2010HEV prevalence with a moderate spread of HIV infection and AIDS. In Russia, 13 out of 117 HIV\u2010infected patients (11.1%) were found to be anti\u2010HEV seropositive. This differed significantly from the frequency observed in the normal population (1.7%) but not from the frequency in a matching control, high\u2010risk group consisting of male prisoners (8.0%). No difference in the frequency of anti\u2010HEV IgG seropositivity was found between groups of HIV\u2010infected men subdivided by sexual orientation. The rate of anti\u2010HEV seropositivity increased with the progression of HIV infection, reaching 43.3% in AIDS patients and 38.1% in those who died from AIDS. In Belarus, anti\u2010HEV IgG seropositivity was not found among 20 HIV\u2010infected subjects nor among individuals from the control risk group, which consisted of 25 intravenous drug users. In conclusion, HEV infection may have common transmission mechanisms (risk factors) with HIV infection rather than represent an additional opportunistic infection in AIDS.<\/jats:p>","DOI":"10.1046\/j.1365-2893.1997.00050.x","type":"journal-article","created":{"date-parts":[[2003,11,26]],"date-time":"2003-11-26T01:19:41Z","timestamp":1069809581000},"page":"279-283","source":"Crossref","is-referenced-by-count":43,"title":["Antibody to hepatitis E virus in HIV\u2010infected individuals and AIDS patients"],"prefix":"10.1111","volume":"4","author":[{"given":"M. S.","family":"Balayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. E.","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. I.","family":"Mikhailov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. G.","family":"Rytick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. F.","family":"Eremin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. I.","family":"Danilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. I.","family":"Shevelev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C.","family":"Gorbacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Y.","family":"Pankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,11,25]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0928-0197(93)90027-3"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.47.1.257"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(92)90180-L"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.4.801"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890420321"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92224-4"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92235-7"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90598-3"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90091-8"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92149-4"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.1996.tb00095.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91734-1"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0928-0197(94)90054-X"},{"key":"e_1_2_1_15_2","first-page":"361","article-title":"Acquired immunodeficiency syndrome (AIDS)\u2014Data as at 20 November 1996","volume":"71","year":"1996","journal-title":"WHO Wkly Epidem Rec"},{"key":"e_1_2_1_16_2","first-page":"355","article-title":"Acquired immunodeficiency syndrome (AIDS): WHO provisional working estimates of adult HIV prevalence","volume":"70","year":"1995","journal-title":"WHO Wkly Epidem Rec"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(11)80802-9"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90598-B"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80196-6"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.1996.tb00096.x"},{"key":"e_1_2_1_21_2","first-page":"104","article-title":"Hepatitis E in a non\u2010endemic region: antibodies to hepatitis E virus in different population groups","volume":"3","author":"Fedorova OE","year":"1996","journal-title":"Vopr Virusol"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2893.1997.00050.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2893.1997.00050.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T10:57:58Z","timestamp":1698490678000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2893.1997.00050.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1046\/j.1365-2893.1997.00050.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2893.1997.00050.x","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}